Litigation Details for UCB, Inc. v. Alza Corporation (D. Del. 2015)
✉ Email this page to a colleague
UCB, Inc. v. Alza Corporation (D. Del. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-12-21 |
| Court | District Court, D. Delaware | Date Terminated | 2016-03-17 |
| Cause | 28:2201 Declaratory Judgment | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | |
| Patents | 6,403,120; 6,419,958 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in UCB, Inc. v. Alza Corporation
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for UCB, Inc. v. Alza Corporation (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-12-21 | 1 | 22-104, Osmotica listed United States Patent Numbers 6,403,120 and 6,419,958 in the FDA’s publication…unenforceability of United States Patent Number 6,440,457 (“the ’457 patent”) under 28 U.S.C. §§ 2201 and… TH E PATENT IN SUIT 9. The United States Patent and Trademark Office (“…Evaluations (the “Orange Book”), as patents “with respect to which a claim of patent infringement could reasonably…that led to the ’457 patent. Thus, any claim for infringement of the ’457 patent is barred, in whole | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
